Back to results
US 2026/0216057 A1Published application
Pharmaceutical compositions for herpes virus
AssigneeAssembly Biosciences, Inc.
InventorsZhixin ZONG, Nicole WHITE, Yi WU
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for treating and/or inhibiting the development or progression of diseases or disorders caused by, or associated with, herpes virus infection. In particular, provided are long-acting injectable depot pharmaceutical compositions comprising a helicase-primase inhibitor; methods for their manufacture; and the use of said pharmaceutical compositions as a medicament and for the treatment of diseases or disorders caused by, or associated with, herpes virus.
Claims29
A long-acting injectable depot pharmaceutical composition comprising:
- (a) a helicase-primase inhibitor or a pharmaceutically acceptable salt thereof;
- and
- (b) one or more pharmaceutically acceptable excipients;
- wherein the helicase-primase inhibitor has a human biological terminal half-life of 10 hours or more.
1 more element
(canceled)
Dependencies are inferred from the claim text.